These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z, Park A, Wu X, Kaartinen V, Roman BL, Oh SP. Blood; 2008 Jan 15; 111(2):633-42. PubMed ID: 17911384 [Abstract] [Full Text] [Related]
6. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Ruiz-Llorente L, Gallardo-Vara E, Rossi E, Smadja DM, Botella LM, Bernabeu C. Expert Opin Ther Targets; 2017 Oct 15; 21(10):933-947. PubMed ID: 28796572 [Abstract] [Full Text] [Related]
7. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia. Tørring PM, Larsen MJ, Kjeldsen AD, Ousager LB, Tan Q, Brusgaard K. Microvasc Res; 2015 May 15; 99():118-26. PubMed ID: 25892364 [Abstract] [Full Text] [Related]
11. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. Berg J, Porteous M, Reinhardt D, Gallione C, Holloway S, Umasunthar T, Lux A, McKinnon W, Marchuk D, Guttmacher A. J Med Genet; 2003 Aug 15; 40(8):585-90. PubMed ID: 12920067 [Abstract] [Full Text] [Related]
12. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia. Fernandez-L A, Garrido-Martin EM, Sanz-Rodriguez F, Pericacho M, Rodriguez-Barbero A, Eleno N, Lopez-Novoa JM, Düwell A, Vega MA, Bernabeu C, Botella LM. Hum Mol Genet; 2007 Jul 01; 16(13):1515-33. PubMed ID: 17420163 [Abstract] [Full Text] [Related]
15. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1. Fernandez-L A, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Morales C, Restrepo CM, Ramirez JR, Coto E, Lenato GM, Bernabeu C, Botella LM. Hum Mutat; 2006 Mar 01; 27(3):295. PubMed ID: 16470589 [Abstract] [Full Text] [Related]
16. Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia. Kim MJ, Kim ST, Lee HD, Lee KY, Seo J, Lee JB, Lee YJ, Oh SP. BMC Med Genet; 2011 Oct 03; 12():130. PubMed ID: 21967607 [Abstract] [Full Text] [Related]
17. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia. Hwan Kim Y, Vu PN, Choe SW, Jeon CJ, Arthur HM, Vary CPH, Lee YJ, Oh SP. Circ Res; 2020 Oct 09; 127(9):1122-1137. PubMed ID: 32762495 [Abstract] [Full Text] [Related]
20. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E. Proc Natl Acad Sci U S A; 2000 Mar 14; 97(6):2626-31. PubMed ID: 10716993 [Abstract] [Full Text] [Related] Page: [Next] [New Search]